Classification of non-Hodgkin lymphoma in Algeria according to the World Health Organization classification

Nadia Boudjerra; Anamarija M. Perry; Josée Audouin; Jacques Diebold; Bharat N. Nathwani; Kenneth A. Maclennan; Hans K. Müller-Hermelink; Martin Bast; Eugene Boilesen; James O. Armitage; Dennis D. Weisenburger

doi:10.3109/10428194.2014.939967

Classification of non-Hodgkin lymphoma in Algeria according to the World Health Organization classification

Nadia Boudjerra, Anamarija M. Perry, Josée Audouin, Jacques Diebold, Bharat N. Nathwani, Kenneth A. Maclennan, Hans K. Müller-Hermelink, Martin Bast, Eugene Boilesen, James O. Armitage, Dennis D. Weisenburger

Research output: Contribution to journal › Article › peer-review

8 Scopus citations

Abstract

Abstract The relative distribution of non-Hodgkin lymphoma (NHL) subtypes differs markedly around the world. The aim of this study was to report this distribution in Algeria. A panel of four hematopathologists classified 197 consecutive cases according to the World Health Organization classification, including 87.3% B-cell and 12.7% T- or natural killer (NK)-cell NHLs. This series was compared with similar cohorts from Western Europe (WEU) and North America (NA). Algeria had a significantly higher frequency of diffuse large B-cell lymphoma (DLBCL: 52.8%) and a lower frequency of follicular lymphoma (FL: 13.2%) compared with WEU (DLBCL: 32.2%; FL: 20.0%) and NA (DLBCL: 29.3%; FL: 33.6%). The frequency of mantle cell lymphoma was lower in Algeria (2.5%) compared with WEU (8.3%). Smaller differences were also found among the NK/T-cell lymphomas. In conclusion, we found important differences between Algeria and Western countries, and further epidemiologic studies are needed to explain these differences.

Original language	English (US)
Pages (from-to)	965-970
Number of pages	6
Journal	Leukemia and Lymphoma
Volume	56
Issue number	4
DOIs	https://doi.org/10.3109/10428194.2014.939967
State	Published - Apr 1 2015

Keywords

Algeria
Diffuse large B-cell lymphoma
Epidemiology
Non-Hodgkin lymphoma

ASJC Scopus subject areas

Hematology
Oncology
Cancer Research

Access to Document

10.3109/10428194.2014.939967

Cite this

Boudjerra, N., Perry, A. M., Audouin, J., Diebold, J., Nathwani, B. N., Maclennan, K. A., Müller-Hermelink, H. K., Bast, M., Boilesen, E., Armitage, J. O., & Weisenburger, D. D. (2015). Classification of non-Hodgkin lymphoma in Algeria according to the World Health Organization classification. Leukemia and Lymphoma, 56(4), 965-970. https://doi.org/10.3109/10428194.2014.939967

@article{1065fa911a5c4bab8dad8ef5c0156b45,

title = "Classification of non-Hodgkin lymphoma in Algeria according to the World Health Organization classification",

abstract = "Abstract The relative distribution of non-Hodgkin lymphoma (NHL) subtypes differs markedly around the world. The aim of this study was to report this distribution in Algeria. A panel of four hematopathologists classified 197 consecutive cases according to the World Health Organization classification, including 87.3% B-cell and 12.7% T- or natural killer (NK)-cell NHLs. This series was compared with similar cohorts from Western Europe (WEU) and North America (NA). Algeria had a significantly higher frequency of diffuse large B-cell lymphoma (DLBCL: 52.8%) and a lower frequency of follicular lymphoma (FL: 13.2%) compared with WEU (DLBCL: 32.2%; FL: 20.0%) and NA (DLBCL: 29.3%; FL: 33.6%). The frequency of mantle cell lymphoma was lower in Algeria (2.5%) compared with WEU (8.3%). Smaller differences were also found among the NK/T-cell lymphomas. In conclusion, we found important differences between Algeria and Western countries, and further epidemiologic studies are needed to explain these differences.",

keywords = "Algeria, Diffuse large B-cell lymphoma, Epidemiology, Non-Hodgkin lymphoma",

author = "Nadia Boudjerra and Perry, {Anamarija M.} and Jos{\'e}e Audouin and Jacques Diebold and Nathwani, {Bharat N.} and Maclennan, {Kenneth A.} and M{\"u}ller-Hermelink, {Hans K.} and Martin Bast and Eugene Boilesen and Armitage, {James O.} and Weisenburger, {Dennis D.}",

note = "Publisher Copyright: {\textcopyright} 2014 Informa UK, Ltd.",

year = "2015",

month = apr,

day = "1",

doi = "10.3109/10428194.2014.939967",

language = "English (US)",

volume = "56",

pages = "965--970",

journal = "Leukemia and Lymphoma",

issn = "1042-8194",

publisher = "Informa Healthcare",

number = "4",

}

TY - JOUR

T1 - Classification of non-Hodgkin lymphoma in Algeria according to the World Health Organization classification

AU - Boudjerra, Nadia

AU - Perry, Anamarija M.

AU - Audouin, Josée

AU - Diebold, Jacques

AU - Nathwani, Bharat N.

AU - Maclennan, Kenneth A.

AU - Müller-Hermelink, Hans K.

AU - Bast, Martin

AU - Boilesen, Eugene

AU - Armitage, James O.

AU - Weisenburger, Dennis D.

PY - 2015/4/1

Y1 - 2015/4/1

N2 - Abstract The relative distribution of non-Hodgkin lymphoma (NHL) subtypes differs markedly around the world. The aim of this study was to report this distribution in Algeria. A panel of four hematopathologists classified 197 consecutive cases according to the World Health Organization classification, including 87.3% B-cell and 12.7% T- or natural killer (NK)-cell NHLs. This series was compared with similar cohorts from Western Europe (WEU) and North America (NA). Algeria had a significantly higher frequency of diffuse large B-cell lymphoma (DLBCL: 52.8%) and a lower frequency of follicular lymphoma (FL: 13.2%) compared with WEU (DLBCL: 32.2%; FL: 20.0%) and NA (DLBCL: 29.3%; FL: 33.6%). The frequency of mantle cell lymphoma was lower in Algeria (2.5%) compared with WEU (8.3%). Smaller differences were also found among the NK/T-cell lymphomas. In conclusion, we found important differences between Algeria and Western countries, and further epidemiologic studies are needed to explain these differences.

AB - Abstract The relative distribution of non-Hodgkin lymphoma (NHL) subtypes differs markedly around the world. The aim of this study was to report this distribution in Algeria. A panel of four hematopathologists classified 197 consecutive cases according to the World Health Organization classification, including 87.3% B-cell and 12.7% T- or natural killer (NK)-cell NHLs. This series was compared with similar cohorts from Western Europe (WEU) and North America (NA). Algeria had a significantly higher frequency of diffuse large B-cell lymphoma (DLBCL: 52.8%) and a lower frequency of follicular lymphoma (FL: 13.2%) compared with WEU (DLBCL: 32.2%; FL: 20.0%) and NA (DLBCL: 29.3%; FL: 33.6%). The frequency of mantle cell lymphoma was lower in Algeria (2.5%) compared with WEU (8.3%). Smaller differences were also found among the NK/T-cell lymphomas. In conclusion, we found important differences between Algeria and Western countries, and further epidemiologic studies are needed to explain these differences.

KW - Algeria

KW - Diffuse large B-cell lymphoma

KW - Epidemiology

KW - Non-Hodgkin lymphoma

UR - http://www.scopus.com/inward/record.url?scp=84929103914&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84929103914&partnerID=8YFLogxK

U2 - 10.3109/10428194.2014.939967

DO - 10.3109/10428194.2014.939967

M3 - Article

C2 - 25012941

AN - SCOPUS:84929103914

SN - 1042-8194

VL - 56

SP - 965

EP - 970

JO - Leukemia and Lymphoma

JF - Leukemia and Lymphoma

IS - 4

ER -

Classification of non-Hodgkin lymphoma in Algeria according to the World Health Organization classification

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this